Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
Public ClinicalTrials.gov record NCT07053917. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of the current studies is to evaluate the safety and tolerability of psilocybin in patients with chronic stroke.
Study identification
- NCT ID
- NCT07053917
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 20 participants
Conditions and interventions
Conditions
- Stroke
- Chronic Stroke
- Intracerebral Haemorrhage
- Intracerebral Haemorrhage (ICH)
- Intracerebral Hemorrhage Basal Ganglia
- Ischemic Stroke
- Ischemic Stroke and Hemorrhagic Stroke
- Hemiparesis After Stroke
- Hemiplegia Following Ischemic Stroke
- Hemiplegia and Hemiparesis
- Hemiplegia and/or Hemiparesis Following Stroke
- Middle Cerebral Artery Stroke
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 8, 2026
- Primary completion
- Jan 31, 2027
- Completion
- Feb 28, 2027
- Last update posted
- Feb 12, 2026
2026 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Johns Hopkins | Baltimore | Maryland | 21287 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07053917, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 12, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07053917 live on ClinicalTrials.gov.